EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation

Ji-Jing Yan iD, Jong-Min Kim iD, Sang-Ik Cho, Hyori Kim, Kyungmin Kwak iD, Hyunil Kim, Eun-Jee Oh, Jaeseok Yang, Chung-Gyu Park iD, Jong Cheol Jeong iD, Beom Seok Kim iD

Xenotransplantation · 2026-03 · 33 (2)

DOI: 10.1111/xen.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 09.04.2026. Verfasst von Ji-Jing Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Seoul National University Bundang Hospital, Seongnam, South Korea. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Islets of Langerhans Transplantation, Cell-Free Nucleic Acids, Graft Rejection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In pig‐to‐nonhuman primate islet transplantation, reliable, sensitive biomarkers are needed to detect graft damage at an early stage before irreversible islet loss occurs. In our study, we investigated donor‐derived cell‐free DNA (dd‐cfDNA) as an early, noninvasive biomarker of graft injury by analyzing its correlation with porcine C‐peptide levels, complement activation markers, and donor‐specific antibodies (DSAs).

Methods

Streptozotocin‐induced diabetic cynomolgus monkeys received 50 000–100 000 IEQ/kg of intraportal islets from quadruple‐knockout (QKO; GGTA1 , CMAH , B4GALNT2 , and A3GALT2 ) pigs. Cohort 1 received antithymocyte globulin (ATG), tacrolimus, mycophenolate mofetil (MMF), and anti‐inflammatory agents (i.e., anakinra, adalimumab, and tocilizumab), whereas Cohort 2 received the same regimen plus rituximab and crovalimab. Graft function and immune responses were assessed by measuring porcine C‐peptide levels, complement activation markers, histology, and dd‐cfDNA kinetics.

Results

Cohort 1 showed transient porcine C‐peptide secretion with marked dd‐cfDNA elevation at 7 d postoperatively that coincided with complement activation (i.e., C5a and membrane attack complex (MAC)) and dense CD3 + T‐cell and CD68 + macrophage infiltration, which resulted in early graft loss. Cohort 2 maintained stable C‐peptide levels, lower dd‐cfDNA levels, and reduced complement activation with improved graft preservation. Moreover, dd‐cfDNA correlated negatively with C‐peptide and positively with C5a but not with MAC. In both cohorts, DSA levels remained unchanged.

Conclusions

Our study revealed that dd‐cfDNA levels correlate with graft damage and C5a in QKO porcine islet xenografts, which corroborates dd‐cfDNA utility as an early biomarker for predicting instant blood‐mediated inflammatory reaction (IBMIR). These findings indicate that dd‐cfDNA may be able to detect early islet xenograft damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousIslets of Langerhans TransplantationCell-Free Nucleic AcidsGraft RejectionAnimalsSwineBiomarkersMacaca fascicularisGraft SurvivalHeterograftsDiabetes Mellitus, ExperimentalMaleC-Peptide

Stichwörter der Autor:innen

complement activationdonor‐derived cell‐free DNAislet xenotransplantationporcine c‐peptide

Substanzen

BiomarkersCell-Free Nucleic AcidsC-Peptide

Autor:innen und Institutionen

  • Division of Nephrology, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Department of Animal Health and Welfare, College of Health and Medical Sciences, Cheongju University, Cheongju, South Korea.
  • Department of Medical Sciences, Graduate School of The Catholic University, Seoul, South Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
  • Optipharm Inc., Cheongju, South Korea.
  • Department of Laboratory Medicine, Seoul St. Mary's Hospital, Research and Development Institute For In Vitro Diagnostic Medical Devices, College of Medicine, The Catholic University, Seoul, South Korea.

ORCID-Profile: Ji-Jing Yan, Jong-Min Kim, Kyungmin Kwak, Chung-Gyu Park, Jong Cheol Jeong, Beom Seok Kim

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Yan, J. J., Kim, J. M., Cho, S. I., Kim, H., Kwak, K., Kim, H., Oh, E. J., Yang, J., Park, C. G., Jeong, J. C., & Kim, B. S. (2026). Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation. Xenotransplantation, 33(2). https://doi.org/10.1111/xen.70126

Vancouver

Yan JJ, Kim JM, Cho SI, Kim H, Kwak K, Kim H, et al. Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation. Xenotransplantation. 2026;33(2). doi:10.1111/xen.70126

BibTeX
@article{Yan2026,
  author = {Yan, Ji-Jing and Kim, Jong-Min and Cho, Sang-Ik and Kim, Hyori and Kwak, Kyungmin and Kim, Hyunil and Oh, Eun-Jee and Yang, Jaeseok and Park, Chung-Gyu and Jeong, Jong Cheol and Kim, Beom Seok},
  title = {Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {2},
  doi = {10.1111/xen.70126}
}
Kostenlos starten →